4NE1

Accolade DB:4NE1 Stock Report

Last Price

€9.95

Market Cap

€762.2m

7D

-0.5%

1Y

-13.5%

Updated

02 Oct, 2023

Data

Company Financials +

4NE1 Stock Overview

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

4NE1 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Accolade, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Accolade
Historical stock prices
Current Share PriceUS$9.95
52 Week HighUS$14.40
52 Week LowUS$6.85
Beta1.74
1 Month Change-19.11%
3 Month Change-17.08%
1 Year Change-13.48%
3 Year Changen/a
5 Year Changen/a
Change since IPO-70.74%

Recent News & Updates

Recent updates

Shareholder Returns

4NE1DE HealthcareDE Market
7D-0.5%-3.0%-1.2%
1Y-13.5%23.1%14.3%

Return vs Industry: 4NE1 underperformed the German Healthcare industry which returned 24.4% over the past year.

Return vs Market: 4NE1 underperformed the German Market which returned 16.1% over the past year.

Price Volatility

Is 4NE1's price volatile compared to industry and market?
4NE1 volatility
4NE1 Average Weekly Movement6.4%
Healthcare Industry Average Movement3.8%
Market Average Movement4.4%
10% most volatile stocks in DE Market8.5%
10% least volatile stocks in DE Market2.2%

Stable Share Price: 4NE1 is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 4NE1's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20072,370Raj Singhhttps://www.accolade.com

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services.

Accolade, Inc. Fundamentals Summary

How do Accolade's earnings and revenue compare to its market cap?
4NE1 fundamental statistics
Market Cap€762.17m
Earnings (TTM)-€147.86m
Revenue (TTM)€353.23m

2.1x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4NE1 income statement (TTM)
RevenueUS$370.84m
Cost of RevenueUS$203.83m
Gross ProfitUS$167.01m
Other ExpensesUS$322.24m
Earnings-US$155.24m

Last Reported Earnings

May 31, 2023

Next Earnings Date

Oct 04, 2023

Earnings per share (EPS)-2.05
Gross Margin45.03%
Net Profit Margin-41.86%
Debt/Equity Ratio62.3%

How did 4NE1 perform over the long term?

See historical performance and comparison